Photodynamic therapy—new approaches

Seminars in Surgical Oncology

Volumn 5, Issue 1, 1989, Pages 6-16

  Dougherty, Thomas J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

cancer; Photofrin II; porphyrins

Indexed keywords

HEMATOPORPHYRIN DERIVATIVE; PHOTOFRIN II; PORPHYRIN;

BLADDER TUMOR; BREAST CANCER; CANCER; GAMMA RADIATION; HUMAN; IRRADIATION; PHOTOSENSITIZATION; REVIEW;

ANIMAL; HUMAN; IN VITRO; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PHOTOCHEMOTHERAPY; PORPHYRINS;

EID: 0024562221     PISSN: 87560437     EISSN: 10982388     Source Type: Journal    
DOI: 10.1002/ssu.2980050104     Document Type: Article

References (79)

1. Photodynamic therapy
2. Uber die wirkung fluoreszirenden stoffe auf infusoria
3. Sensitized photochemical processes in biological systems
4. Etudes sur les aspects offerts par des tumeur experimentales examinee a la lumiere de woods
5. The Structure of the active component of hematoporphyrin derivative
6. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light
7. Hematoporphyrin derivative: A possible aid in the diagnosis and therapy of carcinoma of the bladder
8. The use of a derivative of hematoporphyrin in tumor detection
9. Probing the structure of the tumor‐localizing derivative of hematoporphyrin by reductive cleavage with LIAIH4
10. The structure of the active material in hematoporphyrin derivative
11. Studies on the structure of porphyrins contained in Photofrin II
12. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse
13. Fiberoptic bronchoscopic photoradiation in experimentally induced canine lung cancer
14. Fluorescence bronchoscopy for localizing early bronchial cancer and carcinoma in situ. In:
15. Clinical application of a new endoscopic technique for detection of in situ bronchial carcinoma
16. Fluorescence fiberoptic bronchoscopy in the diagnosis of early stage lung cancer
17. Hematoporphyrin derivative as a tumor marker in the detection and localization of pulmonary malignancy
18. Detection and localization of in situ carcinoma of the bladder with hematoporphyrin derivative
19. Hematoporphyrin derivative photoradiation therapy for the treatment of intraocular tumors. Examination of acute normal ocular tissue toxicity
20. Laserbehandlung von blasentumoren nach photosensibilisierung mit hematoporphyrin‐derivat
21. Photobleaching of porphyrins used in photodynamic therapy and implications for therapy
22. The theory of photodynamic therapy dosimetry: Consequences of photodestruction of sensitizers
23. Photobleaching of photofrin II as a means of eliminating skin photosensitivity
24. 3H cells with different oncogenic potential
25. In vitro cellular effects of hematoporphyrin derivative
26. Ultrastructural changes in lymphoma cells treated with hematoporphyrin and light
27. Protoporphyrin‐induced photodynamic effects on transport processes across the membrane of human erythrocytes. Biochim Biophys
28. Photodynamic action of protoporphyrin. IX. On human erythrocytes: Cross‐linking of membrane proteins
29. Hematoporphyrin derivative‐induced photosensitivity of mitochondrial succinate dehydrogenase and selected cytosolic enzymes of R323OAC mammary adenocarcinomas of rats
30. Aspects of the cellular uptake and retention of hematoporphyrin derivative and their correlation with the biological response to PRT in vitro
31. Photodynamic destruction of cultured human bladder tumor cells by hematoporphyrin derivative: Effects of porphyrin molecular aggregation
32. Tumor‐localizing components of porphyrin preparation hematoporphyrin derivative
33. Retention and photodynamic effects of hematoporphyrin derivative in cells after prolonged cultivation in the presence of porphyrin
34. Photodynamic effect on DNA and cell survival of human cells sensitized by hematoporphyrin
35. DNA single‐strand breaks and sister chromatid exchanges induced by treatment with hematoporphyrin and light or by x‐rays in human NHIK 3025 cells
36. Comparison of mutagenicity and induction of sister chromatid exchange in Chinese hamster cells exposed to hematoporphyrin derivative photoradiation, ionizing radiation or ultraviolet radiation
37. Temperature rise during photoradiation therapy of malignant tumors
38. Photosensitization of malignant tumors
39. Photoradiation therapy of endobronchial tumors using the photodynamic effect of hematoporphyrin derivative
40. Untreated bronchogenic carcinoma
41. Lung cancer treatment by photodynamic therapy alone: Survival for more than three years
42. Bronchoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma: A 5 year experience
43. Photoradiation therapy with hematoporphyrin derivative in early and stage I lung cancer
44. A randomized comparative study of the safety and efficacy of photodynamic therapy using Photofrin II combined with palliative radiotherapy versus palliative radiotherapy alone in patients with inoperable obstructive non‐small cell bronchogenic carcinoma: A preliminary report
45. Nd‐YAG laser followed by radiation for treatment of airway lesions
46. Photodynamic therapy with hematoporphyrin derivative in the management of superficial papillary transitional cell carcinoma of bladder:
47. Photoradiation therapy of gynecological malignancies
48. Photodynamic therapy of generalized neoplasms after photosensitization with hematoporphyrin derivative
49. Photodynamic therapy for cancer of the lower female genital tract
50. Photodynamic therapy of ascites tumours within the peritoneal cavity
51. Role of photodynamic therapy in the management of early cancers of the upper aerodigestive tract
52. Photoradiation therapy in the treatment of malignant brain tumors. A phase I (feasibility) study
53. Phototherapy in malignant brain tumors
54. An approach to the treatment of ocular malignant melanomas
55. Microcirculation modifications by localized microwave hyperthermia and hematoporphyrin phototherapy
56. Dose effects relationships in a mouse mammary tumor
57. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor
58. Studies on the mechanism of tumor destruction by photoradiation therapy (PRT)
59. Interaction of photodynamic therapy and hyperthermia: Tumor response and cell survival studies after treatment in vivo
60. Identification of singlet oxygen as the cytotoxic agent in photo‐inactivation of a murine tumor
61. Interaction of hyperthermia and photoradiation therapy
62. Papers presented at the Clayton Foundation Conference on Photodynamic Therapy
63. Meso‐tetra (hydroxyphenyl) porphyrins, a new class of potent tumor photosensitizers with favourable selectivity